Evidence map›Paper›PMID 24797263›Full record

ArticleMolecular & cellular proteomics : MCP2014

Proteomic analysis of the epidermal growth factor receptor (EGFR) interactome and post-translational modifications associated with receptor endocytosis in response to EGF and stress.

Jiefei Tong, Paul Taylor, Michael F Moran

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 115 citations in OpenAlex.

  1. Article
  2. Beyond the membrane: rethinking EGFR signaling in physiology and cancer.Cellular and molecular life sciences : CMLS · 2026
    Review
  3. mBio · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. ErbBs in Lens Cell Fibrosis and Secondary Cataract.Investigative ophthalmology & visual science · 2023
    Article
  18. Article
  19. International journal of molecular sciences · 2023
    Review
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jiefei TongFrom the ‡The Hospital For Sick Children, Program in Molecular Structure and Function, Princess Margaret Cancer Centre, and Department of Molecular Genetics, University of Toronto. Peter Gilgan Centre for Research and Learning, 686 Bay Street, Toronto M5G 0A4, Canada.
Paul TaylorFrom the ‡The Hospital For Sick Children, Program in Molecular Structure and Function, Princess Margaret Cancer Centre, and Department of Molecular Genetics, University of Toronto. Peter Gilgan Centre for Research and Learning, 686 Bay Street, Toronto M5G 0A4, Canada.
Michael F MoranFrom the ‡The Hospital For Sick Children, Program in Molecular Structure and Function, Princess Margaret Cancer Centre, and Department of Molecular Genetics, University of Toronto. Peter Gilgan Centre for Research and Learning, 686 Bay Street, Toronto M5G 0A4, Canada m.moran@utoronto.ca.
Princess Margaret Cancer Centre · CAUniversity of Toronto · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Aberrant expression, activation, and stabilization of epidermal growth factor receptor (EGFR) are causally associated with several human cancers. Post-translational modifications and protein-protein interactions directly modulate the signaling and trafficking of the EGFR. Activated EGFR is internalized by endocytosis and then either recycled back to the cell surface or degraded in the lysosome. EGFR internalization and recycling also occur in response to stresses that activate p38 MAP kinase. Mass spectrometry was applied to comprehensively analyze the phosphorylation, ubiquitination, and protein-protein interactions of wild type and endocytosis-defective EGFR variants before and after internalization in response to EGF ligand and stress. Prior to internalization, EGF-stimulated EGFR accumulated ubiquitin at 7 K residues and phosphorylation at 7 Y sites and at S(1104). Following internalization, these modifications diminished and there was an accumulation of S/T phosphorylations. EGFR internalization and many but not all of the EGF-induced S/T phosphorylations were also stimulated by anisomycin-induced cell stress, which was not associated with receptor ubiquitination or elevated Y phosphorylation. EGFR protein interactions were dramatically modulated by ligand, internalization, and stress. In response to EGF, different E3 ubiquitin ligases became maximally associated with EGFR before (CBL, HUWE1, and UBR4) or after (ITCH) internalization, whereas CBLB was distinctively most highly EGFR associated following anisomycin treatment. Adaptin subunits of AP-1 and AP-2 clathrin adaptor complexes also became EGFR associated in response to EGF and anisomycin stress. Mutations preventing EGFR phosphorylation at Y(998) or in the S(1039) region abolished or greatly reduced EGFR interactions with AP-2 and AP-1, and impaired receptor trafficking. These results provide new insight into spatial, temporal, and mechanistic aspects of EGFR regulation.

Indexed as

Adaptor Protein Complex 2AnisomycinAnti-Bacterial AgentsBiological TransportCell LineEndocytosisEnzyme ActivationEpidermal Growth FactorErbB ReceptorsHEK293 CellsHumansp38 Mitogen-Activated Protein KinasesPhosphorylationProtein Processing, Post-TranslationalSignal TransductionStress, PhysiologicalAdaptor Protein Complex 2AnisomycinAnti-Bacterial AgentsEGFR protein, humanEpidermal Growth FactorErbB Receptorsp38 Mitogen-Activated Protein KinasesTranscription Factor AP-1Ubiquitin-Protein Ligases

Identifiers

PMID24797263
PMCPMC4083106
OpenAlexW2110625124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.